N
Nikos Maniadakis
Researcher at Eli Lilly and Company
Publications - 88
Citations - 3173
Nikos Maniadakis is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Cost effectiveness & Health care. The author has an hindex of 22, co-authored 87 publications receiving 2670 citations. Previous affiliations of Nikos Maniadakis include European Society of Cardiology & Pharmacia.
Papers
More filters
Journal ArticleDOI
European Society of Cardiology: Cardiovascular Disease Statistics 2017
Adam Timmis,Nick Townsend,Chris Gale,Rick Grobbee,Nikos Maniadakis,Marcus Flather,Elizabeth Wilkins,Lucy Wright,Rimke C. Vos,Jeroen J. Bax,Maxim Blum,Fausto J. Pinto,Panos Vardas +12 more
TL;DR: The Atlas confirmed that high-income and middle-income ESC member countries, where the facilities for the contemporary treatment of coronary disease were best developed, were often those in which declines in coronary mortality have been most pronounced.
Journal ArticleDOI
Efficiency measurement of health care: a review of non-parametric methods and applications.
TL;DR: Applications to hospitals and to the wider context of general health care are reviewed and the empirical evidence is that public rather than private provision is more efficient.
Journal ArticleDOI
The economic burden of coronary heart disease in the UK
TL;DR: Coronary heart disease is a leading public health problem in the UK in terms of the economic burden from disease and cost estimates would be substantially understated if informal care/productivity costs were excluded.
Journal Article
The economic burden of back pain in the UK.
TL;DR: Overall, back pain is one of the most costly conditions for which an economic analysis has been carried out in the UK and this is in line with findings in other countries.
Journal ArticleDOI
Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment
Larissa Fabritz,Eduard Guasch,Charalambos Antoniades,Isabel Bardinet,Gerlinde Benninger,Timothy R. Betts,Eva Brand,Günter Breithardt,Gabriela Bucklar-Suchankova,A. John Camm,A. John Camm,David Cartlidge,Barbara Casadei,Winnie Chua,Harry J.G.M. Crijns,Jon Deeks,Stéphane N. Hatem,Françoise Hidden-Lucet,Stefan Kääb,Nikos Maniadakis,Stephan Martin,Lluís Mont,Holger Reinecke,Moritz F. Sinner,Ulrich Schotten,Taunton R. Southwood,Monika Stoll,Panos E. Vardas,Reza Wakili,Andrew West,André Ziegler,Paulus Kirchhof +31 more
TL;DR: A roadmap to develop a set of clinical markers that reflect the major causes of AF in patients is proposed to transform the insights into the mechanisms causing AF into a format that can underpin future personalized strategies to prevent and treat AF, ultimately informing better patient care.